Edição Nº 01 · Outubro 2026
KernMAGAZINE

Ciência & Fronteira

Lithuania's biotechnology scene: The new life sciences hub?

An essay on the Lithuanian scene.

By Marcelo Correia · Issue Nº 01 · 3 min read

Bioeconomia nos Bálticos — arte de vanguarda, estilo suprematista
Bioeconomia nos Bálticos — arte de vanguarda, estilo suprematista

Lithuania is a small country in the Baltics. As an old Soviet republic, the country took countless measures to make sure that never again a giant empire could strip their freedom.

The country has 35 years of independence and is now one of the most promising hubs for science and technology, following the example of their neighbor Estonia, which is now "the most digitalized country in Europe", as they claim.

Lithuania, like Estonia, follows a different way to present itself. Both claim to be a "Startup-like Country", with strong investments in science and technology, free market and digital policies, even digital citizenship, as the e-Estonia project offers.

Lithuania is following its own steps, focusing on biotech, health, and industrial sectors, as well as the financial sector. The nation is looking to be a new bioeconomy hub, focusing on the diverse area of biotechnology. The country points out 5 big clusters, each focused on different areas like medical devices, biopharma, marine biotechnology, and the list goes on, following the Invest Lithuania 2025 Report, which was used as the main resource for this work.

Life sciences is one of the main focuses. Following the same report, it is said that the country's GDP share in the sector is about 2.7%, which is one of the reasons companies like the biotech giant Thermo Fisher are getting interested in the country. Another point in favor of Lithuania is that more than 57% of its younger workforce has higher education, and more than 85% of workers between 25 and 34 years old speak English fluently. But the country doesn't only look at its own workforce; they sell themselves as a great target for international talent and use this to attract big companies.

As the cluster of the biopharma sector, Vilnius is where Thermo Fisher is located, along with local companies like Northway. More than just attracting big foreign companies, the smart play in Lithuania's strategy is to build their own big companies in these sectors. Northway is a good example of a successful national company: focused on bioprocesses in the beginning, it has now expanded into cell culture, healthcare, and more.

“The smart play in Lithuania's strategy is to build their own big companies in these sectors.”

BioCity is a hub created by the Lithuanian private sector that brings together laboratories from various companies in the bioeconomy to stimulate research, development, and new discoveries.

Kaunas is the site for medical devices, hosting companies like Kitron, an Electronic Manufacturing Services (EMS) provider. Even though Kitron does not only serve the medical sector, it is a strong company from Norway that shows, once again, the Baltic country's power of attraction.

I could write an article on every aspect of Lithuania's biotech or bioeconomy. We could talk about marine biotechnology and chemical research in Klaipėda, or how the industrial biotech scene in Panevėžys is evolving. But while Lithuania has incredible points in its favor, there is something else we have to talk about.

Russia is a shadow always haunting the country. As pointed out in an article in The Atlantic, the fear of an invasion is real, and measures have been discussed even with neighboring nations like Poland. For a country thinking about a shining future and trusting in stability, this could sound contradictory. Since their main business is focused on Europe, leaders in government and the private sector are looking to expand to the USA and certainly thinking about Asia.

“Russia is a shadow always haunting the country.”

The crisis in Europe could be a double-edged sword for them: they could fill some gaps, but some business could also drop. Still, the final outlook is positive. The minds behind the country's ideas have shown a strong perception of the situation around them, and that is the big thing.

Lithuania is fresh air for life sciences in general, not just in Europe but for the world. Now we just need to see how the country deals with a crisis, because that is the real test for any good idea.

“Lithuania is fresh air for life sciences in general, not just in Europe but for the world.”

◆

Keep reading

TechnoKabalah: Um conto sobre o futuro →